Literature DB >> 7988185

Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list.

F Lofaso1, P Verschueren, J L Rande, A Harf, F Goldenberg.   

Abstract

We investigated the prevalence of sleep-disordered breathing in 20 outpatients on a heart transplant waiting list. All were younger than 60 years and had severe stable cardiac failure with a cardiac index below 2.5 L/min/m2 and a left ventricular ejection fraction below 25%. Nine patients (45%) exhibited ten or more apneas and hypopneas per hour of sleep (apneic group). In all patients but one, apneas and hypopneas were predominantly of the central type and occurred during Cheyne-Stokes respiration. There were no statistically significant differences between the apneic and nonapneic groups of patients in terms of age (51 +/- 5 years vs 49 +/- 11), body mass index (24 +/- 4 kg/m2 vs 22 +/- 3), cardiac index (1.87 +/- 0.35 L/min/m2 vs 1.84 +/- 0.40), isotopic left ventricular ejection fraction (13 +/- 5 vs 12 +/- 3%), arterial blood gas, or pulmonary function tests. Hypnogram characteristics showed poorer sleep quality in the apneic group than in the nonapneic group, with a larger number of arousals; this difference was found both for arousals lasting more than 30 s (8 +/- 5/h vs 4 +/- 2) and for arousals lasting less than 30 s (18 +/- 16/h vs 5 +/- 6) and was associated with increased wakefulness after sleep onset in the apneic group (138 +/- 82 min vs 84 +/- 45). Arousals were strongly associated with hyperpneic phases of Cheyne-Stokes respiration. We conclude that sleep-disordered breathing is common in patients with end-stage heart disease and adversely affects the quality of sleep.

Entities:  

Mesh:

Year:  1994        PMID: 7988185     DOI: 10.1378/chest.106.6.1689

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  Prevalence of Cheyne-Stokes respiration in modern treated congestive heart failure.

Authors:  Gerrit Hagenah; Dennis Beil
Journal:  Sleep Breath       Date:  2008-09-13       Impact factor: 2.816

2.  Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes.

Authors:  P Moruzzi; S Sarzi-Braga; M Rossi; M Contini
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

3.  Prevalence and treatment of breathing disorders during sleep in patients with heart failure.

Authors:  Shahrokh Javaheri; Laura Wexler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

4.  Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study.

Authors:  Yoko M Nakao; Kenji Ueshima; Shinji Yasuno; Shigetake Sasayama
Journal:  Heart Vessels       Date:  2014-10-28       Impact factor: 2.037

Review 5.  Heart failure and sleep disorders.

Authors:  Gianfranco Parati; Carolina Lombardi; Francesco Castagna; Paola Mattaliano; Pasquale Perrone Filardi; Piergiuseppe Agostoni
Journal:  Nat Rev Cardiol       Date:  2016-05-12       Impact factor: 32.419

6.  Resolution of sleep-disordered breathing with a biventricular assist device and recurrence after heart transplantation.

Authors:  Emmanuelle Vermes; Hortense Fonkoua; Matthias Kirsch; Thibaud Damy; Laurent Margarit; Marie-Line Hillion; Luc Hittinger; Marie-Pia d'Ortho
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

Review 7.  Sleep disorders and quality of life in renal transplant recipients.

Authors:  Miklos Zsolt Molnar; Marta Novak; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

8.  Sleep dysfunction in heart failure.

Authors:  Shahrokh Javaheri
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

Review 9.  Central sleep apnea: implications for congestive heart failure.

Authors:  Arturo Garcia-Touchard; Virend K Somers; Lyle J Olson; Sean M Caples
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

10.  Cheyne-stokes respiration and prognosis in modern-treated congestive heart failure.

Authors:  Gerrit Hagenah; Antonia Zapf; Jan Bernd Schüttert
Journal:  Lung       Date:  2009-12-12       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.